4-635913-T-C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000283.4(PDE6B):​c.655T>C​(p.Tyr219His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00659 in 1,606,172 control chromosomes in the GnomAD database, including 52 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0046 ( 8 hom., cov: 33)
Exomes 𝑓: 0.0068 ( 44 hom. )

Consequence

PDE6B
NM_000283.4 missense

Scores

2
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:7

Conservation

PhyloP100: 1.98

Publications

13 publications found
Variant links:
Genes affected
PDE6B (HGNC:8786): (phosphodiesterase 6B) Photon absorption triggers a signaling cascade in rod photoreceptors that activates cGMP phosphodiesterase (PDE), resulting in the rapid hydrolysis of cGMP, closure of cGMP-gated cation channels, and hyperpolarization of the cell. PDE is a peripheral membrane heterotrimeric enzyme made up of alpha, beta, and gamma subunits. This gene encodes the beta subunit. Mutations in this gene result in retinitis pigmentosa and autosomal dominant congenital stationary night blindness. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2009]
PDE6B Gene-Disease associations (from GenCC):
  • retinitis pigmentosa 40
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine
  • congenital stationary night blindness autosomal dominant 2
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • congenital stationary night blindness
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.015854329).
BP6
Variant 4-635913-T-C is Benign according to our data. Variant chr4-635913-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 92769.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00455 (694/152378) while in subpopulation NFE AF = 0.00811 (552/68040). AF 95% confidence interval is 0.00755. There are 8 homozygotes in GnomAd4. There are 318 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 8 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000283.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PDE6B
NM_000283.4
MANE Select
c.655T>Cp.Tyr219His
missense
Exon 3 of 22NP_000274.3
PDE6B
NM_001440547.1
c.655T>Cp.Tyr219His
missense
Exon 3 of 22NP_001427476.1
PDE6B
NM_001145291.2
c.655T>Cp.Tyr219His
missense
Exon 3 of 22NP_001138763.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PDE6B
ENST00000496514.6
TSL:1 MANE Select
c.655T>Cp.Tyr219His
missense
Exon 3 of 22ENSP00000420295.1
PDE6B
ENST00000255622.10
TSL:1
c.655T>Cp.Tyr219His
missense
Exon 3 of 22ENSP00000255622.6

Frequencies

GnomAD3 genomes
AF:
0.00456
AC:
694
AN:
152260
Hom.:
8
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00152
Gnomad AMI
AF:
0.00439
Gnomad AMR
AF:
0.00281
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00165
Gnomad FIN
AF:
0.00179
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00811
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00441
AC:
1108
AN:
251448
AF XY:
0.00474
show subpopulations
Gnomad AFR exome
AF:
0.00129
Gnomad AMR exome
AF:
0.00185
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00116
Gnomad NFE exome
AF:
0.00758
Gnomad OTH exome
AF:
0.00326
GnomAD4 exome
AF:
0.00681
AC:
9895
AN:
1453794
Hom.:
44
Cov.:
29
AF XY:
0.00672
AC XY:
4863
AN XY:
723822
show subpopulations
African (AFR)
AF:
0.00123
AC:
41
AN:
33314
American (AMR)
AF:
0.00188
AC:
84
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26104
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39662
South Asian (SAS)
AF:
0.00355
AC:
306
AN:
86086
European-Finnish (FIN)
AF:
0.00165
AC:
88
AN:
53418
Middle Eastern (MID)
AF:
0.00174
AC:
10
AN:
5756
European-Non Finnish (NFE)
AF:
0.00820
AC:
9053
AN:
1104658
Other (OTH)
AF:
0.00518
AC:
311
AN:
60080
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
421
842
1262
1683
2104
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
332
664
996
1328
1660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00455
AC:
694
AN:
152378
Hom.:
8
Cov.:
33
AF XY:
0.00427
AC XY:
318
AN XY:
74510
show subpopulations
African (AFR)
AF:
0.00151
AC:
63
AN:
41596
American (AMR)
AF:
0.00281
AC:
43
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00166
AC:
8
AN:
4832
European-Finnish (FIN)
AF:
0.00179
AC:
19
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00811
AC:
552
AN:
68040
Other (OTH)
AF:
0.00237
AC:
5
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
41
82
123
164
205
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00641
Hom.:
10
Bravo
AF:
0.00456
TwinsUK
AF:
0.00728
AC:
27
ALSPAC
AF:
0.00752
AC:
29
ESP6500AA
AF:
0.00136
AC:
6
ESP6500EA
AF:
0.00744
AC:
64
ExAC
AF:
0.00456
AC:
553
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.00654
EpiControl
AF:
0.00634

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:7
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 29, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PDE6B: BS2

Retinitis pigmentosa Uncertain:1Benign:1
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.

May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:2
Feb 18, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

May 31, 2017
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Congenital stationary night blindness autosomal dominant 2 Benign:1
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.15
CADD
Benign
10
DANN
Benign
0.18
DEOGEN2
Benign
0.25
T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.52
D
LIST_S2
Benign
0.81
T
M_CAP
Benign
0.011
T
MetaRNN
Benign
0.016
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N
PhyloP100
2.0
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-0.41
N
REVEL
Uncertain
0.36
Sift
Benign
0.54
T
Sift4G
Benign
0.54
T
Polyphen
0.020
B
Vest4
0.68
MVP
0.48
MPC
0.23
ClinPred
0.0011
T
GERP RS
1.6
Varity_R
0.042
gMVP
0.58
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
1.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs62295357; hg19: chr4-629702; API